The program will be held virtually via the Zoom platform.
Thanks to the sponsors: Cascadia Capital, Davis Wright Tremaine LLP, and Miller Nash LLP
Telehealth and virtual medicine, supported by high speed networks, are growing at an exponential rate. And there are new advancements in health data analysis using AI and Machine Learning. This is having a major impact on how care is delivered, costs are managed, and how health care organizations function. COVID has accelerated these developments, but they were already in motion and are now directed towards a post-COVID future. As telehealth and virtual medicine progress, new issues emerge around privacy, equity, and access to the underlying broadband technology necessary to make it possible.
This will entail a moderated panel session featuring health industry leaders who will discuss the telehealth and virtual medicine technology, legal and regulatory environment.
The program is free of charge for FCBA Members and $15.00 for FCBA Non-Members. If you have any issues, please contact Elizabeth Hagerty at firstname.lastname@example.org.
Keynote: John D. Halamka, M.D., M.S., President of the Mayo Clinic Platform
Panel One: Legal and Regulatory Issues
Teri Ohta, National Director, State Regulatory Affairs, T-Mobile
Joanne Charles, Senior Corporate Counsel, Microsoft Corporation
Adam Romney, Partner, Davis Wright Tremaine LLP
Panel Two: Technology and Solutions
David Rice, Partner, Miller Nash LLP
John D. Halamka, M.D., M.S., President of the Mayo Clinic Platform
Peter Ku, Vice President, Sr. Tech Counsel, Providence
Jeffrey Neal, National Director, Federal Sales, T-Mobile for Government, T-Mobile
Angela Moore, CEO of Cynergy Wellness